ACE and allergic disease: For patients who could not tolerate being on angiotensin-converting enzyme inhibitor, angiotensin renin blocker or angiotensin receptor/neprilysin inhibitor due to renal dysfunction, allergies, or intolerance, hydralazine and nitrate combination were administered (pre-admission 1.25% and at discharge 3.85%) (Table 3).